Vienna - Delayed Quote EUR
Pharma Mar, S.A. (PHM.VI)
81.30
+1.45
+(1.82%)
At close: 3:30:16 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
6,027
6,027
-13,446
38,321
25,677
Investing Cash Flow
1,033
1,033
-43,048
10,878
18,472
Financing Cash Flow
-5,350
-5,350
-32,137
-13,370
-27,415
End Cash Position
63,239
63,239
60,024
149,813
113,348
Capital Expenditure
-15,510
-15,510
-15,956
-8,852
-7,803
Issuance of Capital Stock
18,911
18,911
18,606
57,227
33,554
Issuance of Debt
15,414
15,414
6,391
1,543
5,832
Repayment of Debt
-6,506
-6,506
-7,544
-10,201
-15,270
Repurchase of Capital Stock
-18,696
-18,696
-37,901
-50,178
-40,659
Free Cash Flow
-9,483
-9,483
-29,402
29,469
17,874
12/31/2021 - 12/27/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
8E8.MU Elicera Therapeutics AB
0.3040
0.00%
ARGX.VI argenx SE
530.20
+0.88%
PHVS Pharvaris N.V.
15.50
+4.59%
MSCL.TO Satellos Bioscience Inc.
0.6900
+11.29%
STTK Shattuck Labs, Inc.
0.8257
-3.01%
BION.SW BB Biotech AG Ord
28.25
-0.70%
PVLA Palvella Therapeutics, Inc.
26.11
-1.69%
ONC BeiGene, Ltd.
254.84
+2.29%
CLSD Clearside Biomedical, Inc.
0.8237
+3.54%
UCB.BR UCB SA
147.35
+0.41%